Allergy Asthma and Clinical Immunology

译名:变态反应、哮喘与临床免疫学

SCIEJCR Q2

3-5

2026

影响因子区间

平台估算

投稿周期

5%

2025

中国作者发文占比

2760 USD;2270 GBP;2610 EUR

费用说明

收费

期刊简介:Allergy, Asthma & Clinical Immunology (AACI), the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI), is an open access journal that encompasses all aspects of diagnosis, epidemiology, prevention and treatment of allergic and immunologic disease.By offering a high-visibility forum for new insights and discussions, AACI provides a platform for the dissemination of allergy and clinical immunology research and reviews amongst allergists, pulmonologists, immunologists and other physicians, healthcare workers, medical students and the public worldwide.AACI reports on basic research and clinically applied studies in the following areas and other related topics: asthma and occupational lung disease, rhinoconjunctivitis and rhinosinusitis, drug hypersensitivity, allergic skin diseases, urticaria and angioedema, venom hypersensitivity, anaphylaxis and food allergy, immunotherapy, immune modulators and biologics, immune deficiency and autoimmunity, T cell and B cell functions, regulatory T cells, natural killer cells, mast cell and eosinophil functions, complement abnormalities.

【译文】过敏、哮喘与临床免疫学(AACI),加拿大过敏和临床免疫学会(CSACI)的官方期刊,是一本涵盖所有过敏和免疫性疾病诊断、流行病学、预防和治疗方面的开放获取期刊。通过提供一个高可见度的论坛,AACI为过敏和临床免疫学研究与综述的传播提供了一个平台,面向全球的过敏学家、呼吸科医生、免疫学家和其他医生、医疗保健工作者、医学生和公众。AACI报道以下领域和其它相关主题的基础研究和临床应用研究:哮喘和职业性肺病、鼻炎和结膜炎、药物超敏反应、过敏性皮肤病、荨麻疹和血管性水肿、毒液超敏反应、过敏性休克和食物过敏、免疫疗法、免疫调节剂和生物制剂、免疫缺陷和自身免疫、T细胞和B细胞功能、调节性T细胞、自然杀伤细胞、肥大细胞和嗜酸性粒细胞功能、补体异常。

出版社
BioMed Central
语言
English
学科
医学
ISSN
1710-1484
eISSN
1710-1492
出版频率
年刊
创刊年份
2005
投稿网址
https://www.editorialmanager.com/aaci/default.aspx
最近更新
2026-04-02 18:16:40
Allergy Asthma and Clinical Immunology

指标当前值近三年趋势
JCR分区Q2
暂无
影响因子区间3-5
暂无